Evidence for the biological activity of the deaminated metabolites of the adrenergic amines.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000187:drug effects*; D003641:Deamination; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography; D005071:Evoked Potentials / Q000187:drug effects*; D005106:Exploratory Behavior / Q000187:drug effects; D006185:Habituation, Psychophysiologic; D008297:Male; D008333:Mandelic Acids / Q000031:analogs & derivatives / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism / Q000494:pharmacology*; D009899:Optic Lobe, Nonmammalian / Q000187:drug effects; D010627:Phenethylamines / Q000378:metabolism / Q000494:pharmacology*; D010648:Phenylacetates; D011817:Rabbits; D013329:Structure-Activity Relationship; D014642:Vanilmandelic Acid / Q000494:pharmacology; D014796:Visual Perception / Q000187:drug effects*
D008333:Mandelic Acids; D010627:Phenethylamines; D010648:Phenylacetates; D014642:Vanilmandelic Acid; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D009638:Norepinephrine